Terminalia Chebula - a Pharmacognistic Account
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
UNIVERSITY of CALIFORNIA Los Angeles Ellagic Acid and Urolithin
UNIVERSITY OF CALIFORNIA Los Angeles Ellagic Acid and Urolithin A Improve Insulin Sensitivity in Diet-Induced Insulin Resistant Mice and Reduce Detrimental Effects of Palmitate Administration in Differentiated C2C12 Myotubes. A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biochemistry, Molecular and Structural Biology by Brenda Chan 2018 © Copyright by Brenda Chan 2018 ABSTRACT OF THE THESIS Ellagic Acid and Urolithin A Improve Insulin Sensitivity in Diet-Induced Insulin Resistant Mice and Reduce Detrimental Effects of Palmitate Administration in Differentiated C2C12 Myotubes. by Brenda Chan Master of Science in Biochemistry, Molecular and Structural Biology University of California, Los Angeles, 2018 Professor Catherine F. Clarke, Chair Insulin resistance has been spreading as food and sedentary lifestyles are becoming more common. Major bodily complications often result, necessitating a search for affordable solutions. Phytochemicals are commonly used in alternative medicine but less so in areas where obesity and T2D prevail. This thesis studies ellagic acid (EA) and its metabolite urolithin A (UA) as potential treatments for insulin resistance, focusing on the main site of glucose uptake, skeletal muscle. In diet-induced insulin-resistant mice, long-term dietary EA&UA administration reduced glucose levels in IPITTs, while UA alone also reduced serum FFA and fasting glucose levels. Mitochondrial turnover and ROS detoxification markers increased with treatment, indicating improved mitochondrial quality control. Differentiated C2C12 mouse myotubes were utilized to study cellular effects of EA and UA. In insulin resistant myotubes, treatment enhanced ATP ii production and reduced ROS, cytotoxicity, and apoptosis. With insulin, UA increased uncoupled respiration while decreasing ROS, implying increased fuel oxidation without adding oxidative stress. -
Mangifera Indica) Cultivars from the Colombian Caribbean
Vol. 11(7), pp. 144-152, 17 February, 2017 DOI: 10.5897/JMPR2017.6335 Article Number: 94A673D62820 ISSN 1996-0875 Journal of Medicinal Plants Research Copyright © 2017 Author(s) retain the copyright of this article http://www.academicjournals.org/JMPR Full Length Research Paper Mangiferin content, carotenoids, tannins and oxygen radical absorbance capacity (ORAC) values of six mango (Mangifera indica) cultivars from the Colombian Caribbean Marcela Morales1, Santiago Zapata1, Tania R. Jaimes1, Stephania Rosales1, Andrés F. Alzate1, Maria Elena Maldonado2, Pedro Zamorano3 and Benjamín A. Rojano1* 1Laboratorio Ciencia de los Alimentos, Universidad Nacional de Colombia, Medellín, Colombia. 2Escuela de nutrición, Universidad de Antioquia, Medellín, Colombia. 3Graduate School, Facultad de Ciencias Agrarias, Universidad Austral de Chile, Chile. Received 18 January, 2017; Accepted 13 February, 2017 Mango is one of the tropical fruits of greater production and consumption in the world, and a rich source of bioactive compounds, with various functional properties such as antioxidant activity. In Colombia, mango’s market is very broad and diverse. However, there are very few studies that determined the content of bioactive secondary metabolites. The objective of this study was to evaluated the content of different metabolites like Mangiferin, carotenoids, tannins, and the antioxidant capacity by oxygen radical absorbance capacity (ORAC) methodology of six cultivars from the Colombian Caribbean region, with total carotenoid values ranging from 24.67 to 196.15 mg of β-carotene/100 g dry pulp; 84.30 to 161.49 mg Catequine eq./100 g dry pulp for the content of condensed tannins, and 91.80 to 259.23 mg/100 g dry pulp for mangiferin content. -
Diabetic Neuropathy)
A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR “AKKINI SELATHUMAM” (DIABETIC NEUROPATHY) Dissertation submitted to THE TAMILNADU DR. MGR. MEDICAL UNIVERSITY CHENNAI-32 For the partial fulfillment of the requirements to the Degree of DOCTOR OF MEDICINE (SIDDHA) BRANCH-I DEPARTMENT OF POTHU MARUTHUVAM DEPARTMENT OF POTHU MARUTHUVAM GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. OCTOBER 2019 GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. BONAFIDE CERTIFICATE This is to certify that the dissertation entitled “A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR AKKINI SELATHUMAM (DIABETIC NEUROPATHY)” is abonafide work done by Dr.RAJENDRAM AJANTHAN (Reg. No.321611008) Govt. Siddha Medical College, Palayamkottai - 627 002 in partial fulfilment of the university rules and regulations for award for MD (S) POTHU MARUTHUVAM (BRANCH-I) under my guidance and supervision during the academic year OCTOBER 2016-2019. Supervisor and Guide Prof. Dr.A.MANOHARAN, MD (S),( Ph.D). Head, Department of PothuMaruthuvam, Govt. Siddha Medical College, Palayamkottai. Name and signature of the HOD Name and signature of the Principal Prof. Dr. A.MANOHARAN, MD (S),( Ph.D). Prof. Dr.S.Victoria,MD(S) Dept. of PothuMaruthuvam, Govt. Siddha Medical College Govt. Siddha Medical College, Palayamkottai. Palayamkottai. GOVERNMENT SIDDHA MEDICAL COLLEGE PALAYAMKOTTAI - 627 002 TAMIL NADU, INDIA. CERTIFICATE Certified that I have gone through the dissertation entitled “A PROSPECTIVE OPEN LABELLED NON RANDOMIZED PHASE-II CLINICAL TRIAL OF “KADUKKAI CHOORANAM FOR AKKINI SELATHUMAM (DIABETIC NEUROPATHY)” submitted by Dr.RAJENDRAM AJANTHAN (Reg. No.321611008) a student of final year MD(S) Department of Pothu Maruthuvam (Branch-I)of this college and the dissertation work has been carried out by the individual only. -
Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities Against Multidrug-R
pathogens Article Large-Scale Screening of 239 Traditional Chinese Medicinal Plant Extracts for Their Antibacterial Activities against Multidrug-Resistant Staphylococcus aureus and Cytotoxic Activities Gowoon Kim 1, Ren-You Gan 1,2,* , Dan Zhang 1, Arakkaveettil Kabeer Farha 1, Olivier Habimana 3, Vuyo Mavumengwana 4 , Hua-Bin Li 5 , Xiao-Hong Wang 6 and Harold Corke 1,* 1 Department of Food Science & Technology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China; [email protected] (G.K.); [email protected] (D.Z.); [email protected] (A.K.F.) 2 Research Center for Plants and Human Health, Institute of Urban Agriculture, Chinese Academy of Agricultural Sciences, Chengdu 610213, China 3 School of Biological Sciences, The University of Hong Kong, Hong Kong 999077, China; [email protected] 4 DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, US/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 8000, South Africa; [email protected] 5 Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou 510080, China; [email protected] 6 College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, China; [email protected] * Correspondence: [email protected] (R.-Y.G.); [email protected] (H.C.) Received: 3 February 2020; Accepted: 29 February 2020; Published: 4 March 2020 Abstract: Novel alternative antibacterial compounds have been persistently explored from plants as natural sources to overcome antibiotic resistance leading to serious foodborne bacterial illnesses. -
Antioxidant Rich Extracts of Terminalia Ferdinandiana Inhibit the Growth of Foodborne Bacteria
foods Article Antioxidant Rich Extracts of Terminalia ferdinandiana Inhibit the Growth of Foodborne Bacteria Saleha Akter 1 , Michael E. Netzel 1, Ujang Tinggi 2, Simone A. Osborne 3, Mary T. Fletcher 1 and Yasmina Sultanbawa 1,* 1 Queensland Alliance for Agriculture and Food Innovation (QAAFI), The University of Queensland, Health and Food Sciences Precinct, 39 Kessels Rd, Coopers Plains, QLD 4108, Australia 2 Queensland Health Forensic and Scientific Services, 39 Kessels Rd, Coopers Plains, QLD 4108, Australia 3 CSIRO Agriculture and Food, 306 Carmody Road, St Lucia, QLD 4067, Australia * Correspondence: [email protected]; Tel.: +617-344-32471 Received: 26 June 2019; Accepted: 20 July 2019; Published: 24 July 2019 Abstract: Terminalia ferdinandiana (Kakadu plum) is a native Australian plant containing phytochemicals with antioxidant capacity. In the search for alternatives to synthetic preservatives, antioxidants from plants and herbs are increasingly being investigated for the preservation of food. In this study, extracts were prepared from Terminalia ferdinandiana fruit, leaves, seedcoats, and bark using different solvents. Hydrolysable and condensed tannin contents in the extracts were determined, as well as antioxidant capacity, by measuring the total phenolic content (TPC) and free radical scavenging activity using the 2, 2-diphenyl-1-picrylhydrazyl (DPPH) assay. Total phenolic content was higher in the fruits and barks with methanol extracts, containing the highest TPC, hydrolysable tannins, and DPPH-free radical scavenging capacity (12.2 2.8 g/100 g dry weight ± (DW), 55 2 mg/100 g DW, and 93% respectively). Saponins and condensed tannins were highest in ± bark extracts (7.0 0.2 and 6.5 0.7 g/100 g DW). -
World Journal of Pharmaceutical Research Vangalapati Et Al
World Journal of Pharmaceutical ReseaRch Vangalapati et al. World Journal of Pharmaceutical SJIF Research Impact Factor 5.045 Volume 3, Issue 6, 2127-2139. Review Article ISSN 2277 – 7105 A REVIEW ON CHEBULINIC ACID FROM MEDICINAL HERBS Surya Prakash DV1 and Meena Vangalapati2* 1 Research scholar, Centre for Biotechnology, Department of Chemical Engineering, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India. 2* Associate Professor, Centre for Biotechnology, Department of Chemical Engineering, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India. Article Received on ABSTRACT 30 June 2014, Chebulinic acid is a phenolic compound found in the fruits of Revised on 25 July 2014, Accepted on 20 August 2014 Terminalia chebula (Haritaki), Phyllanthus emblica (Amla) and seeds of Dimocarpus longan (Longan) species etc. It’s also known as 1,3,6- *Correspondence for Tri-O-galloyl-2,4-chebuloyl-β-D-glucopyranoside. Chebulinic acid is Author extracted from the medicinal herbs using soxhlet extractor, column Dr. Meena Vangalapati chromatography and high pressure liquid chromatography (HPLC) etc. Associate Professor, Centre for It showed many pharmacological activities including inhibition of Biotechnology, Department of cancer cell growth like human leukemia K562 cells, colon Chemical Engineering, Andhra University, adenocarcinoma HT-29 cell lines, anti-neisseria gonorrhoeae activity, Visakhapatnam-530003, inhibiting the contractile responses of cardiovascular muscles activities Andhra Pradesh, India. etc. KEY WORDS: Chebulinic acid, Terminalia chebula, Dimocarpus longan, Phyllanthus emblica, Anticancer activity, HPLC, Astringency. INTRODUCTION Chebulinic acid is a phenolic compound [1,2] commonly found in the fruits of Terminalia chebula, leaves and fruits of Phyllanthus emblica and seeds of Dimocarpus longan species, which has many potential uses in medicine. -
Effect of Seed Size, Pre-Sowing Treatments and Potting Mixture on Seedlings Growth Character and Biomass Production Under Nurser
International Journal of Chemical Studies 2019; 7(4): 1502-1507 P-ISSN: 2349–8528 E-ISSN: 2321–4902 IJCS 2019; 7(4): 1502-1507 Effect of seed size, pre-sowing treatments and © 2019 IJCS Received: 04-05-2019 potting mixture on seedlings growth character Accepted: 06-06-2019 and biomass production under nursery conditions Akoijam Benjamin of Terminalia chebula Retz Department of Forestry & Environmental Science, Manipur University, Imphal, Manipur, India Akoijam Benjamin, Salam Dilip, Gurumayum Ranibala and Naorem Bidyaleima Chanu Salam Dilip Department of Forestry & Environmental Science, Manipur Abstract University, Imphal, Manipur, The experiment conducted aims in improving seed germination, seedling growth and biomass production India of Terminalia chebula. For the experiment, the depulped fruits were graded into three different sizes on the basis of length and were subjected to eight pre-sowing treatments and followed by transplanting Gurumayum Ranibala seedlings in three different potting mixtures. It was evident from the study that large size seeds (L3) Department of Forestry & excelled in all germination, growth and seedling biomass parameters. Among treatments, maximum Environmental Science, Manipur germination parameters were recorded from T8 (nicking at broad end then soaking in ordinary water for University, Imphal, Manipur, 36 hours). Among seed size and pre-sowing treatment combinations, most successful result was observed India from large size seeds subjected to nicking at broad end then soaking in ordinary water for 36 hours (T8L3). Among three different potting mixtures, seedlings transplanted in the potting mixture M3 (Soil: Naorem Bidyaleima Chanu College of Horticulture & Sand: FYM-1:2:3) exerted significantly maximum seedlings growth and biomass production under Forestry, Central Agricultural nursery conditions. -
Molecular Docking Studies of Medicinal Compounds Against Aldose Reductase Drug Target for Treatment of Type 2 Diabetes Pratistha Singh*1, Preeti Yadav2, V.K
Intl. J. Bioinformatics and Biological Sci.: (V. 5 n.2, p. 91-116): December 2017 ©2017 New Delhi Publishers. All rights reserved DOI: 10.5958/2321-7111.2017.00012.9 Molecular Docking Studies of Medicinal Compounds against Aldose reductase Drug Target for Treatment of Type 2 Diabetes Pratistha Singh*1, Preeti Yadav2, V.K. Singh3 and A.K. Singh1 1Department of Dravyaguna, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India 2School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi, India 3Centre for Bioinformatics, School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi, India *Corresponding author: [email protected] ABSTRACT Type 2 Diabetes is a disease that manifests from combined effect of genetic and environmental stress on multiple tissues over a period of time. An enzyme, Aldose Reductase play an important role in oxidative stress and Diabetic Mellitus was selected as a target protein for in silico screening of suitable herbal inhibitors using molecular docking. In the present work best screened ligands Ajoene, 3-O-methyl-D-chiro-inositol (D-pinitol), Butein, Leucopelargonidin, Nimbidinin, Tolbutamide and Coumarin were used for docking calculation and isolated from Allium sativum, Glycine max, Butea monosperma, Thepsia populena, Ficus benghalensis, Azardirachta indica, Nelumbo nucifera, Aegle marmelos respectively. Herbacetin and Quercetin from Thepsia populena. The residues Gly18, Thr19, Trp20, Lys21, Asp43,Val47, Tyr48, Gln49, Asn50, Lys77, His110, Trp111, Thr113, Ser159, Asn160, Asn162, His163, Gln183, Tyr209, Ser210, Pro211, Leu212, Gly213, Ser214, Pro215, Asp216, Ala245, Ile260, Val264, Thr265, Arg268, Glu261, Asn262, Cys298, Ala299 and Leu300 were found conserved with binding site 1, which is major active site involved in interaction. -
A Caenorhabditis Elegans Model for Discovery of Novel Anti-Infectives
fmicb-07-01956 November 30, 2016 Time: 12:40 # 1 REVIEW published: 02 December 2016 doi: 10.3389/fmicb.2016.01956 Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives Cin Kong†, Su-Anne Eng, Mei-Perng Lim and Sheila Nathan* School of Biosciences and Biotechnology, Faculty of Science and Technology, Universiti Kebangsaan Malaysia, Bangi, Malaysia The spread of antibiotic resistance amongst bacterial pathogens has led to an urgent need for new antimicrobial compounds with novel modes of action that minimize the potential for drug resistance. To date, the development of new antimicrobial drugs is still lagging far behind the rising demand, partly owing to the absence of an effective screening platform. Over the last decade, the nematode Caenorhabditis elegans Edited by: Luis Cláudio Nascimento Da Silva, has been incorporated as a whole animal screening platform for antimicrobials. This CEUMA University, Brazil development is taking advantage of the vast knowledge on worm physiology and how it Reviewed by: interacts with bacterial and fungal pathogens. In addition to allowing for in vivo selection Osmar Nascimento Silva, of compounds with promising anti-microbial properties, the whole animal C. elegans Universidade Católica Dom Bosco, Brazil screening system has also permitted the discovery of novel compounds targeting Francesco Imperi, infection processes that only manifest during the course of pathogen infection of the Sapienza University of Rome, Italy host. Another advantage of using C. elegans in the search for new antimicrobials is that *Correspondence: Sheila Nathan the worm itself is a source of potential antimicrobial effectors which constitute part of its [email protected] immune defense response to thwart infections. -
In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: a Case of Padma Hepatenr Formulation
Article In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepatenr Formulation Daniil N. Olennikov 1,*, Nina I. Kashchenko 1,: and Nadezhda K. Chirikova 2,: Received: 28 August 2015 ; Accepted: 30 September 2015 ; Published: 13 October 2015 1 Laboratory of Medical and Biological Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, Sakh’yanovoy Street 6, Ulan-Ude 670-047, Russia; [email protected] 2 Department of Biochemistry and Biotechnology, North-Eastern Federal University, 58 Belinsky Street, Yakutsk 677-027, Russian; [email protected] * Correspondence: [email protected]; Tel.: +7-9021-600-627; Fax: +7-3012-434-243 : These authors contributed equally to this work. Abstract: Chebulic ellagitannins (ChET) are plant-derived polyphenols containing chebulic acid subunits, possessing a wide spectrum of biological activities that might contribute to health benefits in humans. The herbal formulation Padma Hepaten containing ChETs as the main phenolics, is used as a hepatoprotective remedy. In the present study, an in vitro dynamic model simulating gastrointestinal digestion, including dialysability, was applied to estimate the bioaccessibility of the main phenolics of Padma Hepaten. Results indicated that phenolic release was mainly achieved during the gastric phase (recovery 59.38%–97.04%), with a slight further release during intestinal digestion. Dialysis experiments showed that dialysable phenolics were 64.11% and 22.93%–26.05% of their native concentrations, respectively, for gallic acid/simple gallate esters and ellagitanins/ellagic acid, in contrast to 20.67% and 28.37%–55.35% for the same groups in the non-dialyzed part of the intestinal media. -
Wo 2009/114810 A2
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 17 September 2009 (17.09.2009) WO 2009/114810 A2 (51) International Patent Classification: Box#: 19 162, 701 South Nedderman Drive, Arlington, A61K 31/357 (2006.01) A61P 31/12 (2006.01) TX 76019 (US). (21) International Application Number: (74) Agents: BRASHEAR, Jeanne, M . et al; Marshall, Ger- PCT/US2009/037163 stein & Borun LLP, 233 S. Wacker Drive, Suite 6300, Sears Tower, Chicago, IL 60606-6357 (US). (22) International Filing Date: 13 March 2009 (13.03.2009) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, (25) Filing Language: English AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (30) Priority Data: HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, 61/036,8 12 14 March 2008 (14.03.2008) US KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, (71) Applicant (for all designated States except US): THE MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, FLORIDA INTERNATIONAL UINVERSITY NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, BOARD OF TRUSTEES [US/US]; University Park, PC SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, 511, Miami, FL 33 199 (US). -
6 Health Aspects and Antiaflatoxigenic Activity of Phytochemicals in Tree
OF Health Aspects 6 and Antiaflatoxigenic Activity of Phytochemicals in Tree Nuts Russell]. Molyneux, Noreen Mahoney, long H. Kim, and Bruce C. Campbell CONTENTS 6.1 Introduction............................................................................................................................. 95 6.2 Aflatoxinsin Tree Nuts ........................................................................................................... 96 6.3 Allatoxin Resistance Phytochemicals in Tree Nuts................................................................97 6.3.1 Varietal Resistance of Tree Nut Species .....................................................................98 6.3.2 Antiaflatoxigenic Constituents in Specific Tissues .....................................................98 6.4 Isolation and Identification of Walnut Antiatlatoxigenic Constituents...................................99 6.4.1 Bioassay-Directed Fractionation .................................................................................99 6.4.2 Analysis of Hydrolysable Tannin Content in Walnuts ..............................................100 6.4.3 Gallic and Ellagic Acid Content in Tree Nuts...........................................................101 6.4.3.1 Variation of Gallic and Ellagic Acids with Maturity .................................101 6.4.3.2 Variation of Gallic and Ellagic Acids with Cultivar..................................101 6.4.3.3 Structure—Activity Relationships ...............................................................103 6.5 Mechanism